eFFECTOR Therapeutics (EFTR) Financial Statements

eFFECTOR Therapeutics's market cap is currently $941.00. The company's EPS TTM is $-13.315; its P/E ratio is ―; eFFECTOR Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.